Maple Grove, MN – January 28, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Clonidine Hydrochloride Extended-Release Tablets in 0.1 mg strength. Upsher-Smith’s product is AB1-rated to the branded product, KAPVAY® (clonidine ... Read More
Maple Grove, MN – January 13, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Haloperidol Tablets, USP in 0.5 mg, 1 mg, 2 mg, 5 mg, 10 mg and 20 mg strengths. ... Read More
Maple Grove, MN – January 10, 2020 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Fluvoxamine Maleate Tablets in 25 mg, 50 mg and 100 mg strengths.
The fluvoxamine tablet market had U.S. sales ... Read More
DELIVERS THE EFFICACY OF AN INJECTABLE WITH THE CONVENIENCE OF A NASAL SPRAY
Maple Grove, MN – October 2, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith)today announced the launch of Tosymra™ (sumatriptan) Nasal Spray, 10 mg for ... Read More
Maple Grove, MN – August 27, 2019 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of Morphine Sulfate Tablets, CII, 15 and 30 mg. The morphine sulfate tablet market had U.S. sales of approximately ... Read More
Offers Patients and Physicians a Fully Substitutable Generic Alternative with Brand-Quality Support
Vigadrone™ (vigabatrin) for Oral Solution, 500 mg. Upsher-Smith Laboratories, LLC
Maple Grove, MN – July 16, 2018 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch ... Read More
